Filing Details

Accession Number:
0001683168-23-002495
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-18 08:00:05
Reporting Period:
2023-04-17
Accepted Time:
2023-04-18 08:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1729427 Cns Pharmaceuticals Inc. CNSP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705978 Christopher Downs C/O Cns Pharmaceuticals, Inc.
2100 West Loop South, Suite 900
Houston TX 77027
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-17 3,100 $3.20 9,251 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct